Shares of Corbus Pharmaceuticals Holdings Inc. CRBP tumbled 10.18% to $10.15 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index ...

However, investors reacted to limited gains at higher doses. Corbus Pharmaceuticals and Skye Bioscience stocks dropped as all three companies explore CB1 inhibition in obesity treatment.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) stands against the other small-cap biotech stocks. The biotechnology sector is expanding ...

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...

The bank noted that Phase 1 testing for CRB-913 was expected to begin in Q1, with data in the second half of 2025. Piper set a price target for Corbus of $35.For Viking (), Piper cited the company ...

The J.P. Morgan Healthcare Conference is invitation only. Those interested in attending should contact their J.P. Morgan representative for more information. This press release contains certain ...

NORWOOD, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval ...

The statement says Officer Landon Corbus is accused of picking up a woman and slamming her down in a laundry room, causing her glasses to stab her in the eye. The victim also told police Corbus ...

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slid 4.86% to $11.35 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...